NORGES BANK - CONSTELLATION PHARMCETICLS I ownership

Quarter-by-quarter ownership
NORGES BANK ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q2 2021$5,371,000
+7.3%
158,900
-25.7%
0.00%0.0%
Q1 2021$5,005,000214,0000.00%
Other shareholders
CONSTELLATION PHARMCETICLS I shareholders Q3 2021
NameSharesValueWeighting ↓
TRV GP, LLC 3,034,083$41,112,00040.71%
Svennilson Peter 4,677,939$63,386,00033.76%
VHCP Management II, LLC 726,677$9,846,0002.88%
Casdin Capital, LLC 1,556,999$21,097,0002.32%
Cormorant Asset Management, LP 1,271,687$17,231,0001.16%
VHCP Management III, LLC 66,667$903,0000.53%
Hillhouse Capital Management 317,921$4,308,0000.18%
Orbimed Advisors 835,842$11,326,0000.18%
ESSEX INVESTMENT MANAGEMENT CO LLC 66,186$897,0000.13%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 253,400$3,434,0000.13%
View complete list of CONSTELLATION PHARMCETICLS I shareholders